iX Biopharma (SGX:42C) Price-to-Operating-Cash-Flow : (As of Apr. 26, 2024)

View and export this data going back to 2015. Start your Free Trial

What is iX Biopharma Price-to-Operating-Cash-Flow?

As of today (2024-04-26), iX Biopharma's share price is S$0.041. iX Biopharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was S$-0.01. Hence, iX Biopharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for iX Biopharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 10 years, iX Biopharma's highest Price-to-Operating-Cash-Flow Ratio was 44.75. The lowest was 19.75. And the median was 31.25.

SGX:42C's Price-to-Operating-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 17.465
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

iX Biopharma's Cash Flow from Operations per share for the six months ended in Dec. 2023 was S$-0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was S$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 8.40% per year.

During the past 10 years, iX Biopharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 8.40% per year. The lowest was -29.40% per year. And the median was -11.90% per year.

iX Biopharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for iX Biopharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iX Biopharma Price-to-Operating-Cash-Flow Chart

iX Biopharma Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

40.75

iX Biopharma Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	40.75	-	-	-

Competitive Comparison of iX Biopharma's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, iX Biopharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iX Biopharma's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, iX Biopharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where iX Biopharma's Price-to-Operating-Cash-Flow falls into.

iX Biopharma Price-to-Operating-Cash-Flow Calculation

iX Biopharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.041	/	-0.009
	=

iX Biopharma's Share Price of today is S$0.041.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. iX Biopharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was S$-0.01.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

iX Biopharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of iX Biopharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

iX Biopharma (SGX:42C) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » iX Biopharma Ltd (SGX:42C) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Kim Seng Promenade, No. 14-01, Great World City East Lobby, Singapore, SGP, 237994

Website

https://www.ixbiopharma.com

iX Biopharma Ltd is a Singapore-based specialty pharmaceutical and nutraceutical company focused on the development, manufacture, and commercialization of therapies for the treatment of acute and breakthrough pain, and other health conditions. Its products under development are Wafermine and BnoX for pain management, Wafesil for erectile dysfunction, WafeRest for improved sleep quality, and others. Its business segments are Specialty Pharmaceutical and Nutraceutical business segments. The firm's business segments operate in United States of America, Singapore, Australia, and China, of which the majority of the revenue comes from the United States of America. The company generates the majority of its revenue from the sale of specialty pharmaceutical products.

iX Biopharma (SGX:42C) Headlines

No Headlines